ChemFeeds Site Navigation:
Journal Selection:
Search:

1) Plasma Metabolome Changes in Response to PI3K Inhibition (Molecular Cancer Therapeutics) Thursday June 2nd 2016


2) TWIST1 Polymorphism Predicts Bevacizumab Efficacy (Molecular Cancer Therapeutics) Thursday June 2nd 2016


3) Rapid BRAF Mutation Testing in Cell-Free DNA (Molecular Cancer Therapeutics) Thursday June 2nd 2016


4) Targeting ANT2 in EGFR-TKI-Resistant NSCLC (Molecular Cancer Therapeutics) Thursday June 2nd 2016


5) TLR4 and Chemotherapy-Induced Toxicity (Molecular Cancer Therapeutics) Thursday June 2nd 2016


6) miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma (Molecular Cancer Therapeutics) Thursday June 2nd 2016


7) Edelfosine for Prostate Cancer (Molecular Cancer Therapeutics) Thursday June 2nd 2016


8) Dll4 Inhibition in Ovarian Cancer (Molecular Cancer Therapeutics) Thursday June 2nd 2016


9) Targeting Wee1 in a Proneural GBM Model (Molecular Cancer Therapeutics) Thursday June 2nd 2016


10) Trastuzumab Dysregulates HER2 and Inhibits Autophagy (Molecular Cancer Therapeutics) Thursday June 2nd 2016


11) Triglycyl Peptide Linker for ADCs (Molecular Cancer Therapeutics) Thursday June 2nd 2016


12) Therapeutic ADC Targeting SLITRK6 in Bladder Cancer (Molecular Cancer Therapeutics) Thursday June 2nd 2016


13) Knottin-Fc-Drug Con{#x0237}ugate as an Antitumor Agent (Molecular Cancer Therapeutics) Thursday June 2nd 2016


14) TRX-E-002-1 Prevents Ovarian Cancer Recurrence (Molecular Cancer Therapeutics) Thursday June 2nd 2016


15) DI-39 in GBM (Molecular Cancer Therapeutics) Thursday June 2nd 2016


16) Pituitary Tumor Treatment with PI3K/mTOR Inhibitors (Molecular Cancer Therapeutics) Thursday June 2nd 2016


17) PI3K/BMX Combination with BH3 Mimetic in SCLC (Molecular Cancer Therapeutics) Thursday June 2nd 2016


18) Pegfilgrastim and Anticancer Antibodies (Molecular Cancer Therapeutics) Thursday June 2nd 2016


19) Preclinical Evaluation of AMG 337 in HCC (Molecular Cancer Therapeutics) Thursday June 2nd 2016


20) Targeting the BET Family in Colorectal Cancer (Molecular Cancer Therapeutics) Thursday June 2nd 2016


21) Apratoxin A, a Novel Pancreas-Targeting Agent (Molecular Cancer Therapeutics) Thursday June 2nd 2016


22) Stem Cell-Based Gene Therapy for Bladder Cancer (Molecular Cancer Therapeutics) Thursday June 2nd 2016


23) CS-IVa-Be, a Novel IL6R Antagonist, Inhibits IL6/STAT3 (Molecular Cancer Therapeutics) Thursday June 2nd 2016


24) Targeting Hh Pathway by MK-4101 in Medulloblastoma and BCC (Molecular Cancer Therapeutics) Thursday June 2nd 2016


25) DETD-35 Overcomes Acquired Vemurafenib Resistance in Mice (Molecular Cancer Therapeutics) Thursday June 2nd 2016


26) Unbiased Oncology Combination Screen (Molecular Cancer Therapeutics) Thursday June 2nd 2016


27) Erlotinib Distribution in Pancreatic Cancer (Molecular Cancer Therapeutics) Thursday May 5th 2016


28) Predictive Biomarkers of Venetoclax Efficacy in Myeloma (Molecular Cancer Therapeutics) Thursday May 5th 2016


29) miR-532-5p Is an Ovarian Cancer Prognosis Marker (Molecular Cancer Therapeutics) Thursday May 5th 2016


30) Hyperpolarized 13C MRSI-Detectable Changes with GBM Treatment (Molecular Cancer Therapeutics) Thursday May 5th 2016


31) dPCR and RAS Pathway Genotyping for mCRC Anti-EGFR Therapy (Molecular Cancer Therapeutics) Thursday May 5th 2016


32) Vismodegib Reduces Mesothelioma Growth by Affecting Stroma (Molecular Cancer Therapeutics) Thursday May 5th 2016


33) PVT1 Promotes NSCLC Cell Proliferation by Regulating LATS2 (Molecular Cancer Therapeutics) Thursday May 5th 2016


34) Anti-CD20-Mediated Lymphoma Cell Senescence (Molecular Cancer Therapeutics) Thursday May 5th 2016


35) Effects of r-AtHSP70 on Breast Cancer Cells (Molecular Cancer Therapeutics) Thursday May 5th 2016


36) Protein Kinase Inhibitor H89 Enhances Immunotoxin Activity (Molecular Cancer Therapeutics) Thursday May 5th 2016


37) GRP78 Increases PDAC Chemoresistance (Molecular Cancer Therapeutics) Thursday May 5th 2016


38) BRD4 Regulates EZH2 Transcription in Bladder Cancer (Molecular Cancer Therapeutics) Thursday May 5th 2016


39) Antiangiogenic Activity of JQ1 (Molecular Cancer Therapeutics) Thursday May 5th 2016


40) STxB-Based Targeting of Gastric Cancer (Molecular Cancer Therapeutics) Thursday May 5th 2016


41) Polymer Therapeutics Overcome Chemotherapy Resistance (Molecular Cancer Therapeutics) Thursday May 5th 2016


42) CLPTM1L Antibodies for Pancreatic and Lung Cancer Therapy (Molecular Cancer Therapeutics) Thursday May 5th 2016


43) Immunokinase-Based B-Lymphotoxic Delivery of Activated DAPK1 (Molecular Cancer Therapeutics) Thursday May 5th 2016


44) Molecular Basis of VC-PABC Linker Instability (Molecular Cancer Therapeutics) Thursday May 5th 2016


45) FAP-Dependent DR5 Hyperclustering Drives Tumor Cell Death (Molecular Cancer Therapeutics) Thursday May 5th 2016


46) Quaternary Ammonium Linkers for ADCs (Molecular Cancer Therapeutics) Thursday May 5th 2016


47) AB61, a New Potent 7-Deazapurine Nucleoside Cytostatic (Molecular Cancer Therapeutics) Thursday May 5th 2016


48) UAB30 in Kidney and Liver Tumors (Molecular Cancer Therapeutics) Thursday May 5th 2016


49) Bone Marrow-Targeted TKIs for CML (Molecular Cancer Therapeutics) Thursday May 5th 2016


50) Combination of Regorafenib and DHA Increases Efficacy in RCC (Molecular Cancer Therapeutics) Thursday May 5th 2016


51) Intermittent High-Dose Scheduling of PI3K Inhibitor AZD8835 (Molecular Cancer Therapeutics) Thursday May 5th 2016


52) Posaconazole Inhibits the Hedgehog Signaling Pathway (Molecular Cancer Therapeutics) Thursday May 5th 2016


53) Bortezomib Inhibits Giant Cell Tumor of Bone (Molecular Cancer Therapeutics) Thursday May 5th 2016


54) SAHA Enhances Radiosensitization of Cisplatin in Lung Cancer (Molecular Cancer Therapeutics) Thursday May 5th 2016


55) HDACi Sensitize Myeloma Cells to Reovirus (Molecular Cancer Therapeutics) Thursday May 5th 2016


56) ABCG2 and ABCB1 Limit Efficacy of Dasatinib in Brainstem Glioma (Molecular Cancer Therapeutics) Thursday May 5th 2016


57) STAT3 and NF-{kappa}B Inhibition by EC-70124 Affects Prostate CSCs (Molecular Cancer Therapeutics) Thursday May 5th 2016


58) Inhibition of STAT3 in 3D Models of PDAC (Molecular Cancer Therapeutics) Thursday May 5th 2016


59) G1T28, a Novel CDK4/6 Inhibitor, Reduces Myelotoxicity (Molecular Cancer Therapeutics) Thursday May 5th 2016


60) PGC1{alpha} in Cancer Metabolism and Its Therapeutic Implications (Molecular Cancer Therapeutics) Thursday May 5th 2016


61) The Future of Oncolytic Virotherapy with Reovirus (Molecular Cancer Therapeutics) Thursday May 5th 2016


62) 3D Tumor Growth Assays with Low-Passage Patient Tumors (Molecular Cancer Therapeutics) Tuesday April 5th 2016


63) Precision Oncology: Moores Cancer Center Experience (Molecular Cancer Therapeutics) Tuesday April 5th 2016


64) AR Compromises Cytotoxicity of NK Cells against HCC (Molecular Cancer Therapeutics) Tuesday April 5th 2016


65) Role of IL11 in Endometrial Cancer (Molecular Cancer Therapeutics) Tuesday April 5th 2016


66) Elevated eIF4E Is a Therapeutic Target in Myeloma (Molecular Cancer Therapeutics) Tuesday April 5th 2016


67) Bevacizumab Prevents Brain Metastases (Molecular Cancer Therapeutics) Tuesday April 5th 2016


68) PTEN as a Context-Dependent Predictive Marker for HER3 Therapy (Molecular Cancer Therapeutics) Tuesday April 5th 2016


69) Nab-Paclitaxel for Pancreatic Cancer (Molecular Cancer Therapeutics) Tuesday April 5th 2016


70) Polymersomes for Peritoneal Carcinomatosis Treatment (Molecular Cancer Therapeutics) Tuesday April 5th 2016


71) ABT-414: A Tumor-Selective EGFR-Targeting ADC (Molecular Cancer Therapeutics) Tuesday April 5th 2016


72) Synergistic Activity of Oncolytic Adenovirus and L-carnosine (Molecular Cancer Therapeutics) Tuesday April 5th 2016


73) Discovery of Targeted Radiotherapies through Femtomedicine (Molecular Cancer Therapeutics) Tuesday April 5th 2016


74) Preclinical Characterization of Entrectinib (Molecular Cancer Therapeutics) Tuesday April 5th 2016


75) Linalool Nanoparticle as Novel Anticancer Agent (Molecular Cancer Therapeutics) Tuesday April 5th 2016


76) An HRE-Binding Py-Im Polyamide Impairs Hypoxic Signaling in Tumors (Molecular Cancer Therapeutics) Tuesday April 5th 2016


77) CDK Inhibition Sensitizes p53-Mutated Cells to Doxorubicin (Molecular Cancer Therapeutics) Tuesday April 5th 2016


78) Mps1 Kinase Inhibitors BAY 1161909 and BAY 1217389 (Molecular Cancer Therapeutics) Tuesday April 5th 2016


79) Identification of a Novel HdmX Inhibitor (Molecular Cancer Therapeutics) Tuesday April 5th 2016


80) Kpn{beta}1 as an Anticancer Target (Molecular Cancer Therapeutics) Tuesday April 5th 2016


81) ERK Inhibitor Resistance (Molecular Cancer Therapeutics) Tuesday April 5th 2016


82) Genomically Driven Cancer Classification (Molecular Cancer Therapeutics) Tuesday April 5th 2016


83) A Tumor-Selective Picornavirus Promotes Tumor Regression (Molecular Cancer Therapeutics) Monday March 7th 2016


84) miR-137 Regulation of Sp1 Protein Translation (Molecular Cancer Therapeutics) Monday March 7th 2016


85) TFAP2C Regulates Breast Cancer through EGFR (Molecular Cancer Therapeutics) Monday March 7th 2016


86) Inflammatory Signaling in Pancreatic Cancer (Molecular Cancer Therapeutics) Monday March 7th 2016


87) T-DM1 Induces Hepatotoxicity (Molecular Cancer Therapeutics) Monday March 7th 2016


88) HMGB1 Predicts Radiotherapy Response in Bladder Cancer (Molecular Cancer Therapeutics) Monday March 7th 2016


89) Prosurvival Role of T-Type Ca2+ Channels in Ovarian Cancer (Molecular Cancer Therapeutics) Monday March 7th 2016


90) HSP90 Inhibition Kills Mutant KRAS Colon Cancer Cells (Molecular Cancer Therapeutics) Monday March 7th 2016


91) Anti-Mesothelin ADC in Pancreatic and Ovarian Cancer (Molecular Cancer Therapeutics) Monday March 7th 2016


92) Metformin Inhibits Urothelial Tumorigenesis (Molecular Cancer Therapeutics) Monday March 7th 2016


93) Tigecycline Inhibits Glioma Growth (Molecular Cancer Therapeutics) Monday March 7th 2016


94) Identifying a Novel MST4 Kinase Inhibitor (Molecular Cancer Therapeutics) Monday March 7th 2016


95) PIT with Viral HER2 Transduction for HER2-Negative Cancer (Molecular Cancer Therapeutics) Monday March 7th 2016


96) CAR Agonist Improves CHOP-Based Chemotherapy (Molecular Cancer Therapeutics) Monday March 7th 2016


97) WIP1 Inhibitor GSK2830371 Potentiates Nutlin-3/RG7388 Sensitivity (Molecular Cancer Therapeutics) Monday March 7th 2016


98) Preclinical Studies of SKLB646 against TNBC (Molecular Cancer Therapeutics) Monday March 7th 2016


View: prev | next


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()